menu

Institute of Dentistry

News and Events menu

Antimicrobial chlorhexidine particle research shortlisted for Royal Society of Chemistry’s Emerging Technologies Prize

Work by a cross-disciplinary team at QM has made it through to the final of the Royal Society of Chemistry’s Emerging Technologies Competition.

2 October 2018

news image

Work by a cross-disciplinary team at QM has made it through to the final of the Royal Society of Chemistry’s Emerging Technologies Competition.

Judges reviewed all applications (90) and selected the QM team to be among the finalists to present their technology at this flagship event for Industry; Chemistry Means Business at QEII Conference Centre in London.

The QM team comprises; Dr Mike Cattell (Institute of Dentistry, IOD), Professor Gleb Sukhorukov (School of Engineering and Material Science, SEMS), Dr Saroash Shahid (IOD), Dr Dong Luo (SEMS), Dr Samiul Hasan (IOD), Dr Rob Whiley (IOD) and Dr Rui Sun (IOD). The winning technologies receive £10K cash prize and support from Competition Industrial Partners; Astra Zeneca, Croda, Diageo, GE Healthcare Life Sciences, Johnson Matthey, Mondelēz, Pfizer & Unilever.

 

 

Return to top